Sun Pharma plunges 6.6% after receiving warning letter from USFDA

The pharma company received a Warning Letter from the USFDA as a result of the September 2014 inspection, for its facility located at Halol, Gujarat in India.

Sun Pharma slipped 6.6% to Rs.738.45 on BSE. The pharma company received a Warning Letter from the US FDA as a result of the September 2014 inspection, for its facility located at Halol, Gujarat in India.

The scrip opened at Rs. 740.1 and has touched a high and low of Rs. 744 and Rs. 732 respectively. So far 3833024(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 190234.92 crore.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1200.7 on 07-Apr-2015 and a 52 week low of Rs. 706.4 on 24-Nov-2015. Last one week high and low of the scrip stood at Rs. 809.3 and Rs. 753.55 respectively.

The promoters holding in the company stood at 54.71 % while Institutions and Non-Institutions held 35.62 % and 9.68 % respectively.

The stock is currently trading above its 200 DMA.